首页> 外文期刊>Annals of Coloproctology >Association of Immune Status with Recurrent Anal Condylomata in Human Immunodeficiency Virus-Positive Patients
【24h】

Association of Immune Status with Recurrent Anal Condylomata in Human Immunodeficiency Virus-Positive Patients

机译:人体免疫缺陷病毒阳性患者的免疫状况与复发性肛门结膜的关联

获取原文
           

摘要

Purpose An anal condyloma is a proliferative disease of the genital epithelium caused by the human papillomavirus. This condition is most commonly seen in male homosexuals and is frequently recurrent. Some reports have suggested that immunosuppression is a risk factor for recurrence of a condyloma. Thus, we investigated the risk factors for a recurrent anal condyloma in human immunodeficiency virus (HIV)-positive patients. Methods We retrospectively analyzed 85 consecutive patients who were diagnosed with and underwent surgery for an anal condyloma from January 2007 to December 2011. Outcomes were analyzed based clinical and immunologic data. Results Recurrent anal condylomata were found in 25 patients (29.4%). Ten cases (40.0%) were within postoperative 3 months. At postoperative 6 months, the CD4 lymphocyte count in the recurrent group was lower than it was in the nonrecurrent group (P = 0.023). Conclusion CD4-mediated immunosuppression is a risk factor for recurrent anal condylomata in HIV-positive patients.
机译:目的肛门尖锐湿疣是人类乳头瘤病毒引起的生殖器上皮增生性疾病。这种情况最常见于男性同性恋者,并且经常复发。一些报告表明免疫抑制是尖锐湿疣复发的危险因素。因此,我们调查了人类免疫缺陷病毒(HIV)阳性患者复发性肛门尖锐湿疣的危险因素。方法回顾性分析2007年1月至2011年12月连续诊治并诊断为肛门尖锐湿疣的85例患者的临床资料,并根据临床和免疫学资料进行分析。结果25例患者中有肛门复发,占29.4%。术后3个月内有10例(40.0%)。术后6个月,复发组的CD4淋巴细胞计数低于非复发组(P = 0.023)。结论CD4介导的免疫抑制是HIV阳性患者复发性肛门湿疣的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号